Transaction Overview On December 31, 2024, Park West Asset Management LLC (Trades, Portfolio) made a strategic decision to reduce its holdings in LENSAR Inc (NA
ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. ( LNSR) (”LENSAR” or the ”Company”) today announced that a majority of the independent m
ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. ( LNSR) (”LENSAR” or ”the Company”), a global medical technology company focused on adva
Revenue: $13.5 million in Q3 2024, a 38% increase from Q3 2023.Gross Margin: $6.3 million, representing a 46% gross margin percentage.Net Loss: $1.5 million or
Alphatec Holdings Inc. (ATEC) stock experienced a significant price surge of 5.19%, reaching $9.33 per share. The trading volume hit 928,012 shares, with a turn
/PRNewswire/ -- The global ophthalmology devices market has been categorized as a part of the global healthcare equipment market. The parent market, the global...
Today's Daily Dose brings you news about the earnings date of Adverum, near-term catalyst of bluebird bio, Predictive Oncology's private placement of common stock, and analyst rating of Sunesis Pharma.